StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.81+0.03 (+0.63%)

Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%

Lifevantage operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Lifevantage's operating income for the twelve months ending Jun 30, 2026 was $6.10M, down 50.0% year over year. For fiscal 2026 it was $6.10M, down 50.0% from the year before. Over ten years it grew -7.6% a year on average. The highest annual figure on record is $21.46M in fiscal 2012.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026$6.10M-50.0%
FY2025Jun 30, 2025$12.20M+181.6%
FY2024Jun 30, 2024$4.33M+1.7%
FY2023Jun 30, 2023$4.26M-43.8%
FY2022Jun 30, 2022$7.58M-57.0%
FY2021Jun 30, 2021$17.62M+13.9%
FY2020Jun 30, 2020$15.47M+57.6%
FY2019Jun 30, 2019$9.81M-4.9%
FY2018Jun 30, 2018$10.32M+132.0%
FY2017Jun 30, 2017$4.45M-66.8%
FY2016Jun 30, 2016$13.41M-3.5%
FY2015Jun 30, 2015$13.90M-28.5%
FY2014Jun 30, 2014$19.45M+61.2%
FY2013Jun 30, 2013$12.07M-43.8%
FY2012Jun 30, 2012$21.46M+479.6%
FY2011Jun 30, 2011$3.70M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$1.67M-22.4%
Q3 FY2026CQ1 2026Mar 31, 2026$1.68M-58.6%
Q2 FY2026CQ4 2025Dec 31, 2025$487.00K-85.8%
Q1 FY2026CQ3 2025Sep 30, 2025$2.27M-11.8%
Q4 FY2025CQ2 2025Jun 30, 2025$2.15M-26.2%
Q3 FY2025CQ1 2025Mar 31, 2025$4.05M+109.6%
Q2 FY2025CQ4 2024Dec 31, 2024$3.43M–
Q1 FY2025CQ3 2024Sep 30, 2024$2.57M+243.1%
Q4 FY2024CQ2 2024Jun 30, 2024$2.91M+11.8%
Q3 FY2024CQ1 2024Mar 31, 2024$1.93M+21.0%
Q2 FY2024CQ4 2023Dec 31, 2023-$1.26M–
Q1 FY2024CQ3 2023Sep 30, 2023$749.00K-41.9%
Q4 FY2023CQ2 2023Jun 30, 2023$2.60M+74.1%
Q3 FY2023CQ1 2023Mar 31, 2023$1.60M-12.4%
Q2 FY2023CQ4 2022Dec 31, 2022-$1.23M–
Q1 FY2023CQ3 2022Sep 30, 2022$1.29M-72.0%
Q4 FY2022CQ2 2022Jun 30, 2022$1.50M-77.3%
Q3 FY2022CQ1 2022Mar 31, 2022$1.83M-12.6%
Q2 FY2022CQ4 2021Dec 31, 2021-$358.00K-106.6%
Q1 FY2022CQ3 2021Sep 30, 2021$4.61M+31.9%
Q4 FY2021CQ2 2021Jun 30, 2021$6.58M+6.0%
Q3 FY2021CQ1 2021Mar 31, 2021$2.09M-31.2%
Q2 FY2021CQ4 2020Dec 31, 2020$5.45M+49.5%
Q1 FY2021CQ3 2020Sep 30, 2020$3.50M+35.6%
Q4 FY2020CQ2 2020Jun 30, 2020$6.21M+9.5%
Q3 FY2020CQ1 2020Mar 31, 2020$3.03M+35.3%
Q2 FY2020CQ4 2019Dec 31, 2019$3.65M+527.5%
Q1 FY2020CQ3 2019Sep 30, 2019$2.58M+94.7%
Q4 FY2019CQ2 2019Jun 30, 2019$5.67M+31.8%
Q3 FY2019CQ1 2019Mar 31, 2019$2.24M-2.5%
Q2 FY2019CQ4 2018Dec 31, 2018$581.00K-75.0%
Q1 FY2019CQ3 2018Sep 30, 2018$1.32M-5.3%
Q4 FY2018CQ2 2018Jun 30, 2018$4.30M+179.2%
Q3 FY2018CQ1 2018Mar 31, 2018$2.30M+930.5%
Q2 FY2018CQ4 2017Dec 31, 2017$2.33M+232.4%
Q1 FY2018CQ3 2017Sep 30, 2017$1.40M-29.6%
Q4 FY2017CQ2 2017Jun 30, 2017$1.54M–
Q3 FY2017CQ1 2017Mar 31, 2017$223.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$700.00K–
Q1 FY2017CQ3 2016Sep 30, 2016$1.99M–

More Lifevantage figures

See a number that looks wrong?